Stammdaten
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.
Unternehmen & Branche
| Name | biote Corp. |
|---|---|
| Ticker | BTMD |
| CIK | 0001819253 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Care Facilities |
| SIC | 2833 · Medicinal Chemicals & Botanical Products |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 97,7 Mio. USD |
| Beta | 1,29 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 192,219,000 | 27,045,000 | 0.74 | 107,613,000 | -58,539,000 |
| 2025-09-30 | 10-Q | 47,956,000 | 8,188,000 | 0.22 | 111,324,000 | -72,751,000 |
| 2025-06-30 | 10-Q | 48,863,000 | 3,185,000 | 0.10 | 104,798,000 | -85,104,000 |
| 2025-03-31 | 10-Q | 48,992,000 | 13,718,000 | 0.37 | 123,379,000 | -89,981,000 |
| 2024-12-31 | 10-K | 197,191,000 | 3,157,000 | 0.09 | 122,370,000 | -105,928,000 |
| 2024-09-30 | 10-Q | 51,384,000 | 10,702,000 | 0.33 | 101,252,000 | -130,342,000 |
| 2024-06-30 | 10-Q | 49,169,000 | -7,087,000 | -0.21 | 92,900,000 | -143,150,000 |
| 2024-03-31 | 10-Q | 46,804,000 | -4,161,000 | -0.12 | 160,108,000 | -36,027,000 |
| 2023-12-31 | 10-K | 185,360,000 | 3,316,000 | 0.13 | 155,295,000 | -29,397,000 |
| 2023-09-30 | 10-Q | 45,557,000 | 7,530,000 | 0.24 | 149,749,000 | -40,529,000 |
| 2023-06-30 | 10-Q | 49,257,000 | -5,143,000 | -0.25 | 139,052,000 | -46,405,000 |
| 2023-03-31 | 10-Q | 44,843,000 | -6,805,000 | -0.39 | 119,135,000 | -48,538,000 |
| 2022-12-31 | 10-K | 164,957,000 | -969,000 | -0.12 | 111,645,000 | -44,459,000 |
| 2022-09-30 | 10-Q | 41,970,000 | 15,000 | 0.00 | 109,578,000 | -37,178,000 |
| 2022-06-30 | 10-Q | 41,359,000 | -2,606,000 | -0.34 | 115,322,000 | -24,951,000 |
| 2022-03-31 | 10-Q | 37,143,000 | 1,174,482 | 317,947,992 | -21,318,626 | |
| 2021-12-31 | 10-K | 139,396,000 | 11,112,910 | 54,330,000 | 4,125,000 | |
| 2021-09-30 | 10-Q | 35,567,000 | ||||
| 2021-06-30 | 10-Q | 34,750,000 | 13,238,824 | 318,449,460 | 5,000,004 | |
| 2021-03-31 | 10-Q | -3,943,374 | 319,014,540 | -37,686,219 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.